Co-treatment of pancreatic cancer cells with FAKi and PD-H resulted in a synergistic and additive interaction, leading to enhanced tumor cell lysis compared to treatment with either agent alone. This evidence concerns the gene PDP1 and familial pancreatic carcinoma.